Whatever credibility management has left is on the line this week. Can’t make that any more definitive. We’re not necessarily just interested in whether or not DC Vax works and how well, but also interested to know whether or not NWBO is a viable investment.
That has to come directly from management, rather than their plausibly deniable tricycle-riding surrogates.
Market Data 
Markets 
AI
